基础医学与临床 ›› 2012, Vol. 32 ›› Issue (12): 1484-1487.

• 短篇综述 • 上一篇    下一篇

电压门控性钠离子通道Nav 1.7与疼痛的研究进展

刘慧丽,李萍,李民   

  1. 北京大学第三医院麻醉科
  • 收稿日期:2012-01-10 修回日期:2012-05-15 出版日期:2012-12-05 发布日期:2012-11-28
  • 通讯作者: 刘慧丽 E-mail:emilypumch@yahoo.com.cn

Progress on Voltage-gated sodium channel Nav1.7 in pain

  • Received:2012-01-10 Revised:2012-05-15 Online:2012-12-05 Published:2012-11-28
  • Contact: huili LIU E-mail:emilypumch@yahoo.com.cn

摘要: 电压门控性钠通道在疼痛的产生和发展中具有关键性作用。而编码Nav1.7的基因突变可能导致一系列遗传性疼痛相关疾病,提示其在疼痛产生机制中的独特作用,可能成为疼痛治疗的新的药物靶点。

关键词: 疼痛, Nav1.7, 离子通道病

Abstract: Data show that Voltage-gated sodium channels(VGCS) are key molecules in pain processing and development. Mutations in the SCN9A gene encoding for Nav1.7 have been identified as important cellular substrates for different heritable pain syndromes, which suggest new Nav1.7 channel blockers could be useful analgesics in the future.

Key words: pain, Nav1.7, channelopathies